Lista de obras - Bibiana Cabrera - Dominio Público Uruguay

A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.

artículo científico publicado en 2015

Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs).

artículo científico publicado en 2012

Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders

artículo científico publicado en 2016

Búsqueda De Nuevos Biomarcadores De La Cognición En Esquizofrenia

Cannabis use, COMT, BDNF and age at first-episode psychosis

artículo científico publicado en 2017

Cognition and psychopathology in first-episode psychosis: are they related to inflammation?

artículo científico publicado en 2016

Cognitive Reserve Assessment Scale in Health (CRASH): Its Validity and Reliability.

artículo científico publicado en 2019

Detection of early psychotic symptoms: Validation of the Spanish version of the "Symptom Onset in Schizophrenia (SOS) inventory".

artículo científico publicado en 2017

Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis.

artículo científico publicado en 2016

Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study

artículo científico publicado en 2019

Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis.

artículo científico publicado en 2017

Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study

scientific article published on 01 June 2019

Gene-environment interaction as a predictor of early adjustment in first episode psychosis.

artículo científico publicado en 2017

Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

scientific article published on 07 May 2019

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations

artículo científico publicado en 2014

Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study.

artículo científico publicado en 2017

Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?

artículo científico publicado en 2018

Metabolic syndrome or glucose challenge in first episode of psychosis?

artículo científico publicado en 2016

Modelling gene-environment interaction in first episodes of psychosis

artículo científico publicado en 2017

Neutrophil Count Is Associated With Reduced Gray Matter and Enlarged Ventricles in First-Episode Psychosis

artículo científico publicado en 2019

Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History

artículo científico publicado en 2016

Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset

artículo científico publicado en 2017

Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes

artículo científico publicado en 2016

Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study

artículo científico publicado en 2015

Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study

scientific article published on 15 August 2019

The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study

artículo científico publicado en 2017

The impact of cognitive reserve in the outcome of first-episode psychoses: 2-year follow-up study.

artículo científico publicado en 2016

The search for new biomarkers for cognition in schizophrenia

artículo científico publicado en 2015

White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder?

scientific article published on 25 September 2019

Lista de obras de Bibiana Cabrera

A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.

Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs).

Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders

Búsqueda De Nuevos Biomarcadores De La Cognición En Esquizofrenia

Cannabis use, COMT, BDNF and age at first-episode psychosis

Cognition and psychopathology in first-episode psychosis: are they related to inflammation?

Cognitive Reserve Assessment Scale in Health (CRASH): Its Validity and Reliability.

Detection of early psychotic symptoms: Validation of the Spanish version of the "Symptom Onset in Schizophrenia (SOS) inventory".

Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis.

Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study

Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis.

Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study

Gene-environment interaction as a predictor of early adjustment in first episode psychosis.

Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations

Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study.

Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?

Metabolic syndrome or glucose challenge in first episode of psychosis?

Modelling gene-environment interaction in first episodes of psychosis

Neutrophil Count Is Associated With Reduced Gray Matter and Enlarged Ventricles in First-Episode Psychosis

Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History

Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset

Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes

Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study

Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study

The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study

The impact of cognitive reserve in the outcome of first-episode psychoses: 2-year follow-up study.

The search for new biomarkers for cognition in schizophrenia

White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder?